LITERATURE

Treatment and economic burden of mucormycosis in China: Case report review and burden estimation

Jian Y, Wang M, Yu Y, Zhuo Y, Xiao D, Lin S, Xuan J.

Abstract

What is known and objective: Mucormycosis is an opportunistic fungal infection associated with low incidence but high mortality. Few studies have shown the treatment and disease burden of mucormycosis in China. This study aims at collecting all the reported cases to describe the characteristics and treatment patterns and to assess the economic burden of mucormycosis in China.

Publication: https://pubmed.ncbi.nlm.nih.gov/35304764/
Topic(s): Economic Burden
Health Condition(s): Immunology
Year Published: 2022
UAB the University of Alabama at Birmingham home
UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of race, national origin, age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.